The Roberto Clemente Health Clinic in Nicaragua (a project our Agora family helped start two decades ago) is still the only free 24/7 medical lifeline for thousands of families. In 2025 alone, it handled over 20,000 patient visits, delivered babies, saved accident victims, and kept kids healthy enough to stay in school.

On behalf of the entire MTA team, thank you for any gift you can spare this Christmas. You’ll be making “San Roberto” proud.

Julia Guth, the Clinic’s founder and board chair, shares their critical mission below…

– Stephen Prior, Publisher

As 2025 ends, here’s how the year unfolded at our Roberto Clemente Health Clinic – and how your donation played a huge part in the lives of many families in Nicaragua. We are deeply grateful for your generous support.

Throughout 2025, our mission remained steadfast:

To provide both emergency and preventive healthcare to the local community, while working cooperatively with Nicaraguan health authorities. Despite budget pressures, we continued our proud tradition of offering 24/7 emergency care.

With the construction of new roads and increasing regional activity, the Clinic supported over 20,000 patient visits this year. Our outreach team also sustained monthly visits to rural communities, delivering essential care to 100–200 patients each trip.

Preventive health efforts remain a cornerstone of our work. Through our Padrino program, 85 children received school supplies, checkups, deworming treatments, and specialized medical support. We delivered 2,500 clean water jugs to 22 schools and municipalities, provided 50 university scholarships, and distributed food supplements to families in need.

Your support has made stories like these possible:

**Jose** arrived just 30 minutes after a motorcycle accident with head trauma and severe injuries. Our team stabilized him and arranged an urgent transfer to Rivas.

**Eliam**, age 12, lives with a PCI condition requiring tracheostomy and gastrostomy. The Clinic ensured a pediatric gastroenterologist evaluated him and now receives ongoing checkups, medicine, and nutritional formulas.

**Yerlin**, age 8, has significant psychomotor impairments. Thanks to our Padrino program and donors like you, we arranged specialist care, provided a new bed, and continue to supply nutritional supplements and diapers each month.

This year has also tested our resilience. Following the tragic passing of our longtime Operations Director, Gustavo Ibarro, we reorganized local leadership. We also completed an unexpected but mandated $60,000 facility refurbishment to maintain our government certification.

Looking ahead to 2026, we will sustain all critical programs, expand staff training, and acquire new medical equipment, including upgraded ultrasound equipment. We’re also beginning early planning for an expanded clinic facility – an exciting step toward meeting future community needs.

Thank you from the bottom of our hearts for your continued commitment in 2025. We’re seeing increasing costs, so our budget challenges continue. Any additional contribution you can make in 2025 will help us greatly with our 2026 budgeting, including planning staffing, medicines, and equipment needs for next year.

Please see below for donation options and consider our team and the community in your end of year giving. A little bit still goes a long way in Nicaragua.

If you plan to visit Nicaragua in 2026, we gladly welcome you for a tour and a conversation about our current and future programs. Medical and non-medical volunteers are also welcome, always.

A very Happy and Healthy Holidays to you,

Julia C. Guth
Chair, The Roberto Clemente Health Clinic
jguth@nicaclinic.org

YOUR ACTION PLAN

Mail Checks to: Roberto Clemente – Santa Ana Health Clinic, 105 West Monument Street Baltimore, Maryland 21201 (EIN 71-0926873)

Online Paypal or Donor Assisted Fund Donation can be made here.

Contact Christina Olson at colson@nicaclinic.org for any donations of stocks or other commodities.

As we are a 501c3 registered in Maryland, all donations are tax-deductible for those donors that qualify on their tax returns.

FUN FACT FRIDAY

The Roberto Clemente Health Clinic in Nicaragua is named after the Pirates legend who died in a 1972 plane crash while delivering aid to earthquake victims there — a country he’d never even visited.

He insisted on going in person to ensure the supplies reached the people.

Over 50 years later, the free 24/7 clinic that bears his name still saves thousands of lives every year, and locals affectionately call him “San Roberto.”

The post Why Roberto Clemente’s Legacy Still Saves Lives 50 Years Later appeared first on Trade of the Day.

It’s down $30 since that conference.

In the War Room, I told members I was shorting OKLO when it was trading north of $180. It’s now in the $90s. And if it reaches those levels again, I’m shorting it again.

Why? Because the technical reality is about to collide with the hype train at 200 mph.

The Trade That Taught Me Everything

One of the hottest “trades” of 2025 has been in the small modular reactor space. The thinking: the US needs energy for all these data centers, so why not make small nuclear reactors to power towns, neighborhoods, or individual facilities?

Perfect solution, right?

Actually, I’m up over 1300% on my recommendation in this sector – Rolls Royce PLC. But my Rolls recommendation wasn’t for their SMR technology. It was for their aircraft engines and travel exposure.

The SMR technology? Still years away.

Why the “Leaders” Are Pumping the Brakes

There are two actual leaders in this space: GE Vernova and Rolls Royce. Both companies – with real nuclear expertise and billion-dollar R&D budgets – say commercial volume won’t arrive until mid-next decade.

Yet startups with no revenue are trading at billion-dollar valuations on expectations this technology is ready now.

When companies with actual nuclear experience are tempering expectations while startups are screaming higher, you’ve got a classic bubble.

The Technical Realities Nobody Mentions

Regulatory Nightmare: Nuclear reactors must go through design certification, site approval, and construction licenses. Even “modular” designs require full safety analysis. The first U.S. SMR design from NuScale took 6+ years just to get certified.

No Production Lines: SMRs are supposed to be factory-built, but no mass-manufacturing facilities exist. Reactor components require specialized metallurgy, welding, and quality control. Supply chains for nuclear-grade parts take years to establish.

Financing Black Hole: No SMRs have demonstrated cost savings. Every delay inflates projected costs. Utilities prefer predictable returns; SMRs remain unproven.

Skills Shortage: Nuclear construction requires certified welders, nuclear-qualified electricians, and specialized concrete crews. These skills are scarce, creating labor bottlenecks.

Fuel Supply Gap: Many advanced SMRs require HALEU fuel, which has no domestic commercial supply chain. Building HALEU capacity alone takes several years.

First-of-a-Kind Penalties: Initial units take longer, cost more, and require redesigns during construction. Only after multiple builds can SMRs hit promised speed and cost goals.

Your Action Plan

SMR technology will eventually work and transform energy production. But even optimistic projections show 2-4 years for design and licensing, 3-5 years for construction, 2-3 years for testing, plus additional years to scale manufacturing.

The market is pricing commercial deployment as imminent. Reality says 10-15 years minimum.

Companies like OKLO trade at billions with no revenue and technology that won’t be viable this decade. When reality hits, these valuations will crater.

If you want to learn how we’re playing this idea, click here to learn more about Catalyst-Cashouts Live.

The post Why I Told a Room Full of Investors to Sell Nuclear Stocks appeared first on Trade of the Day.

Another strong rally in gold is building as investors and analysts wrestle with the idea that stocks are heading for a correction due to a potential bubble in the AI industry.

Whether correct or not, those doubts are causing the first significant sentiment shift to a risk-off condition since the market’s “Tariff Tantrum” in April 2024, a welcome development for the Gold Bugs.

What is “Risk Off”?

A risk-off situation in the stock market happens when investors ditch high-growth, high-risk assets and rotate into safe harbor assets. That money flies into “safe” assets like treasuries and gold.

The move is usually triggered by fear, recession signals, geopolitical tension, Fed tightening, or a breakdown in market internals.

Looking back over the last month, we’ve watched as the market has struggled to digest all these factors.

The reaction to a risk off move is simple. Spike in volatility and defensive sectors like consumer staples and dividend yielding stocks take the lead.

In short, it’s a warning that the market is bracing for a larger impact.

What Does This Mean For Stocks?

In general, we’ve already seen a lot of damage from the shift to risk off.

Industries like quantum computing, nuclear and eVTOL were all the rage over the summer as investors were in speculation – or risk on – mode.

Names like Joby Aviation (JOBY), Oklo Inc. (OKLO) and Rigetti Computing (RGTI) more than doubled as investors saw opportunities to speculate on the next wave of opportunities in the market.

The excitement seen towards these stocks was a bit of a warning sign from a sentiment perspective as investors tend to get “over their skis” with excitement near short- or long-term tops in stocks. You know, the whole Warren Buffett “Be fearful when others are greedy, and greedy when others are fearful”

As is normally the case, the wild speculation turned to uncertainty in October as murmurs of an AI bubble shifted investor sentiment from speculative driven to safety. This led to the Risk Off trade engagement clearly notable in Rigetti Computing’s chart below.

As a result, stocks are now walking on eggshells as investors await the Fed’s decision on December 10, but let’s be frank… is the Fed going to save stocks right now? Not likely.

What Does it Mean for Gold?

A risk-off rotation is one of the strongest catalysts for gold. It forces capital out of high-beta assets and into vehicles with proven defensive strength.

Gold benefits immediately: no counterparty risk, no balance-sheet assumptions, and historically strong performance during periods of tightening financial conditions.

Add weakening dollar confidence, rising recession signals, and central-bank accumulation, and the risk-off flow becomes a structural tailwind. In short, when markets de-risk, gold becomes the trade.

Gold’s Technical Analysis Says a Breakout is Pending

The technical backdrop for GLD remains firmly bullish as momentum, trend strength, and trader psychology are all aligned in favor of higher prices.

The recent 10% drop reset short-term sentiment and brought shares back to key support at $370, not through it. Corrections like this are considered “healthy” and part of a long-term bull market cycle as short-term traders take the opportunity to lock in profits.

We’ve seen five healthy corrections or consolidations over the last two years, each proving to be a short-term pause in what is otherwise the strongest long-term rally, tallying up more than 150% of gains since 2023.

Here are the technical details:

• 20-Day Moving Average ($377): GLD’s 20-day moving average – what I refer to as the “Trader’s Trendline” just turned bullish on November 25. This tells us that the short-term momentum is building towards a breakout.
• 50-Day Moving Average ($373): This trendline has been in a strong bullish trend since early September and has yet to waiver. Historically the GLD shares have a 67% chance of moving higher each day that the 50-day remains in its current trend. Vegas would kill for those odds!
• Volume Profile: Trading volume on the GLD shares is now increasing after a quiet period following the crescendo of activity at the October highs. This is another indication that the crowd is starting to accumulate gold-related investment again.
• Potential breakout price trigger ($400): Round numbers act as powerful support and resistance because traders anchor decisions around simple levels – example: “I’ll buy it if it gets back to $50.” We saw $400 act as resistance for the GLD shares in October, now a break through that psychological ceiling will trigger a new raly as investors chase prices even higher.

Bottom Line

Gold’s rare 10% pullback was a “Healthy Correction” which was needed to refresh the rally and allow investors a chance to buy at a discount to the recent highs. That pullback has coiled the spring for another shot higher as we head into the New Year.

Investors looking to leverage gold’s continued rally should check out long-dated call options on the underlying U.S. Gold shares (GLD). These options are a value from the perspective of time premium given the GLD’s extremely low historical volatility and strong trend.

Following the trends of the last two year, I’m expecting to see another rally that will target a $460 – $475 price target for the US Gold Fund (GLD). The rally should occur within the next three months as continued uncertainty and the “Fear of Missing Out” attract investors to another fast and aggressive move higher.

How Do You Trade the Rally in the U.S. Gold Fund?

Let me start by disclosing that I am currently long the GLD shares using an options strategy like what I detail below.

The simplest way to play it is to buy and hold the US Gold Fund (GLD). Each share of this widely held exchange traded fund (ETF) represents a fractional ownership interest in a pool of physical gold bullion.

GLD Shares are trading 60% higher in 2025 and remain an attractive alternative to buying physical gold based on the ease of trading and relatively low costs.

Investors looking to leverage the move in GLD shares may consider long-dated options as an attractive approach.

This strategy provides time to allow the long-term bullish trend to play out on GLD shares while offering leveraged returns of more than 10 times those of the ETF alone. The strategy is a relatively basic options alternative requiring level 2 approval from your broker.

My current options strategy: Buying (to open) the June 18, 2026 GLD $290 call, currently trading at $2,530 per contract.

According to Black Scholes pricing model, that option would be worth $8,503 (or more if GLD hits my $470 target before March 1, 2026, a return of 236%.

At expiration – on June 18, 2026 – that same $470 target price would command an intrinsic value of $8,000, a return of 216% compared to roughly 20% for the standard buy-and-hold GLD position.

Here are the comparisons of the returns on investing in the US Gold Shares versus leveraged returns using the option detailed above. Note the 10X-plus leveraged return of the options.

YOUR ACTION PLAN

Of course, as always, please make sure you understand the risks of options trading. Leverage cuts both ways. This options strategy should be employed along with a reasonable exit strategy based on any unforeseen technical breakdown in the GLD shares.

For my purposes, a break below the ETFs 50-day moving average – currently at $372.55 – would act as a stop for the trade.

Stay tuned for more information on my next FREE LIVE TRAINING session in Monument Traders Live (probably on Wednesday, December 10th).

Also we will be posting clips from those sessions on our new YouTube channel.

Follow along by subscribing here.

The post Risk-off Rotation + Technical Reset = Leveraged Opportunity appeared first on Trade of the Day.

This thing has fallen hard into major support, and if Bitcoin finds a floor here, MSTR back toward 200 looks like low hanging fruit.

What I’m Seeing

MSTR is flashing a weekly sniper buy signal after getting absolutely crushed alongside Bitcoin.

The weekly chart setup is what caught my attention – we’re sitting on significant support levels after this washout move.

Here’s the thing about Bitcoin proxies: they amplify moves in both directions. We saw that pain on the way down. But if Bitcoin catches a bid here, MSTR should react faster and stronger than the underlying.

Why This Setup Makes Sense

Here’s what I think is happening: MSTR’s stock price has fallen below the value of their Bitcoin holdings. That feels like an overreaction that should correct.

The weekly sniper buy signal combined with these oversold conditions? That’s the kind of setup where you can risk small for potentially big moves.

The Bitcoin Question

Look, I don’t know if Bitcoin has actually bottomed here. That’s the big question, right?

But when you’re looking at a 30% drop from 126K to 80K, we’re in oversold territory where bounces happen.

And MSTR? It’s just more beaten up than the other Bitcoin plays right now. That’s what creates the opportunity.

How I’m Playing It

I’m using December call spreads to play this bounce idea. The volatility premium on MSTR makes spreads attractive while giving defined risk exposure to any move back toward those 200+ levels.

I’m not chasing this thing if it runs. If Bitcoin rolls over from here, MSTR is going to get ugly fast.

But that weekly buy signal combined with these support levels and the stock trading below asset value? That’s the setup I’m looking for.

Your Action Plan

MSTR might be the cleanest way to play any Bitcoin bounce from these levels. The weekly sniper buy signal, the oversold condition, the fundamental disconnect – it’s all lining up.

Just remember: this is a Bitcoin proxy trade. If crypto stays weak, this goes nowhere. But if Bitcoin finds buyers down here, MSTR should lead that move higher.

Want to know how I’m specifically trading this and to receive more real-time trade ideas?

Click here to learn more about Daily Profits Live.

The post If Bitcoin Finds A Floor, This Is The Play appeared first on Trade of the Day.

Three weeks ago, Bryan was taking heavy artillery fire over his Merck position. At our Houston meetup, every single person cornered him: “What are you doing with Merck? Why is Merck down? What do I do with Merck?” I watched him getting hammered from all directions.

He could have folded. Could have said, “You know what, fine, sell it, take the 80% loss.” That’s what most traders do when a position goes sideways and everyone’s breathing down their necks.

But here’s what Bryan did instead… He looked at that trade again, and nothing fundamental had changed. All the metrics that made him enter Merck were still there. The fundamentals were solid. The valuation was screaming undervalued. The only thing that had changed was the stock price going down.

So instead of panic-selling like everyone wanted, Bryan bought more time. Rolled the position forward.

And you know what happened? As soon as Nvidia crashed and everyone said the AI trade might be over, risk-off money flowed straight into safe, undervalued healthcare.

In less than a month, Bryan turned this absolute dog loser into a winner. Sold it for a gain.

It’s a good reminder about sticking to your methodology when you know the fundamentals are right, even when the market’s telling you you’re an idiot.

Why I’m Telling You This Story

I’m telling you this because right now, Bryan and I are seeing the exact same setup in another stock. And this time, we’re both locked in on it.

Novo Nordisk – ticker NVO – is sitting at five-year lows, down 45% this year while its main competitor, Eli Lilly, is hitting all-time highs and becoming the first trillion-dollar pharmaceutical company.

Two companies in the same exact GLP-1 weight loss space, and one’s at all-time highs while the other is getting destroyed.

This is Novo Nordisk we’re talking about. Last year, their market cap was bigger than Denmark’s entire GDP – $570 billion versus $470 billion. These guys ARE the country. They’re not going anywhere.

Everything That Could Go Wrong Did Go Wrong

Novo had the year from hell, and that’s exactly why this is such a massive opportunity:

Their Alzheimer’s drug got rejected – but that was a hail Mary. Nobody thought taking their GLP-1 drug and applying it to Alzheimer’s would work.

They lost a bidding war with Pfizer. But why would Pfizer even be bidding in this space if they didn’t think the market was massive?

They fired their CEO and hired a new one.

They’re losing market share to Lilly. But the market is so enormous there’s room for multiple players. We’re talking about $52 billion in 2024 growing to $187 billion by 2032. That’s 17% annual growth.

The Numbers Don’t Lie

Here’s what everyone’s missing: Novo’s drugs work. Ozempic for diabetes, Wegovy for weight loss – they’re incredibly effective.

All this Washington talk about clamping down on GLP-1 costs? Pure noise. Nobody pays those list prices. The pharmacy benefit managers negotiate deals, and Novo’s margins aren’t changing much. Meanwhile, they just opened these drugs up to Medicare – way more customers.

Two Ways to Play This

Here’s what everyone’s missing: Novo’s drugs work. Ozempic for diabetes, Wegovy for weight loss – they’re incredibly effective.

All this Washington talk about clamping down on GLP-1 costs? Pure noise. Nobody pays those list prices. The pharmacy benefit managers negotiate deals, and Novo’s margins aren’t changing much.

Meanwhile, they just opened these drugs up to Medicare – way more customers.

The simple play: Just buy the stock. Novo isn’t going out of business.

The sophisticated play: I’m setting up a call spread, which, if you’re a Catalyst-Cashouts subscriber, you will get the details.

Why This Reminds Me of Bryan’s Merck

Quality company with solid fundamentals trading at ridiculous levels because of short-term noise. The market’s throwing the baby out with the bathwater.

The GLP-1 space isn’t going anywhere. Novo has proven drugs, massive market opportunity, and they’re trading like they’re about to go bankrupt.

Bryan’s Merck rescue proved that when you find situations like this, patience gets rewarded.

YOUR ACTION PLAN

The stock could go lower before it goes higher. But the trades that feel most uncomfortable – buying while everyone else is selling – those usually pay off the biggest.

Position size appropriately. Don’t bet the farm. But when you find a quality company at stupid-cheap levels because of temporary problems? That’s when you back up the truck.

Sometimes the worst trades teach you the most about being right when everyone thinks you’re crazy.

Merck taught me that lesson. Now let’s see if Nova can do the same thing.

The post Is This The Next Merck? appeared first on Trade of the Day.

Everyone’s watching the Fed cut probabilities hit 87% and debating whether December’s seasonal strength can carry this market higher. The Nasdaq’s 0.5% bounce had traders buying the AI dip again.

But here’s what caught my attention while everyone else was chasing bitcoin’s recovery: CBOE has been quietly building one of the cleanest bullish setups I’ve seen all month. This thing’s been coiling for a breakout just 5% below its 52-week highs.

Fresh Daily Squeeze Loading Energy

When I say CBOE has a “fresh daily squeeze” forming, picture this: imagine winding up a rubber band. The tighter you twist it, the more energy builds up. When it finally snaps, the release is explosive.

That’s exactly what happens with stock volatility. When a stock moves sideways, volatility contracts like a wound-up rubber band. The longer it stays compressed, the bigger the eventual breakout.

CBOE’s daily chart shows this spring-loading effect happening right now. The Bollinger Bands are pinching together, volume is drying up, and the stock is coiling just below resistance.

Bullish Stacked EMAs Show Institutional Support

Here’s what really gets me excited about this setup: CBOE’s exponential moving averages are stacked bullish across multiple timeframes, creating a foundation of support under current prices.

Picture a stack of stairs climbing upward.

The 20-day EMA sits above the 50-day, which sits above the 100-day, which sits above the 200-day. This creates a ladder of support below current prices where the stock consistently bounces off these trend lines.

Relative Strength Tells the Success Story

CBOE is up 29.5% this year while many stocks struggle to keep pace. That’s textbook relative strength – exactly what institutions want to own when markets get choppy.

When markets get volatile like we saw Monday, the relatively strong stocks bounce first and fastest. CBOE’s been building wealth for months. Now it’s positioned for the next leg higher.

Why the Business Model Works Here

CBOE operates the Chicago Board Options Exchange – essentially the marketplace where options contracts trade. Think of them as the toll booth on the highway of options trading.

Every time traders buy puts or calls, CBOE collects transaction fees. With options volume hitting record levels this year and retail trading staying elevated, their revenue streams keep growing.

The Fed cut expectations hitting 87% doesn’t hurt either. Lower rates typically boost trading activity as investors chase yield and hedge positions more actively.

But honestly? I don’t need the fundamental story.

The chart’s been showing strength for months. Those higher highs, the consistent bounces off support, the ability to hold near all-time highs – this breakout’s been building.

Your Action Plan

With those stacked EMAs providing support and a fresh daily squeeze building pressure, any pullback should be short-lived.

This sets up for a potential play using call options targeting the $262.98 highs.

The risk is obvious – market sentiment could sour, Fed expectations could shift, and profit-taking could hit high-flyers like CBOE. That’s why position sizing matters.

But when technical strength, fundamental tailwinds, and market positioning align like this? These setups can move fast.

The spring is loaded for CBOE to break higher. Sometimes the best opportunities hide while everyone’s watching bitcoin bounce.

If you want to follow my ideas in real-time and receive my trade alerts, then click here to learn more about Daily Profits Live.

The post SL: What Happens When Volatility Gets Compressed This Tight? appeared first on Trade of the Day.

We’re one “average true range” away from SPY records – less than 10 points with a $9 ATR.

But while all eyes are on SPY, I’m watching FSLR set up the cleanest consolidation pattern I’ve seen in weeks.

This isn’t about missing the SPY party. It’s about positioning where the real edge exists.

FSLR Just Hit My Sweet Spot

Take a look at First Solar’s weekly chart…

It had a strong 2024 move… then a healthy pullback… and is now consolidating with a daily squeeze right near all-time highs above $300.

There’s a gap to fill around $264 and support down near $255. If this thing gives me a pullback into that zone, I’m backing up the truck.

This is textbook consolidation after a major move – exactly what you want to see before the next leg higher.

Why Solar Works Here

While SPY grinds higher on light volume, individual names with real structure are setting up mechanical entries. FSLR is building the base for a breakout that could take it well above those $300 highs.

The daily squeeze is tightening. The pattern is clean. The levels are obvious.

YOUR ACTION PLAN

Entry zone: $255 (ideal) to $264 (aggressive) Target: Above $300 all-time highs Strategy: December 19 calls when we hit the zone

This isn’t hope – it’s pattern recognition. Either we get the pullback to proper support levels, or we don’t. Either the consolidation resolves higher, or it doesn’t.

Watch My Full Technical Breakdown and Exact Option Strategy Here

Sometimes the best trades happen while everyone else is watching something different.

The post The Cleanest Squeeze I’ve Seen in Weeks appeared first on Trade of the Day.

I’ve been watching this pattern for weeks. Every time we get above 2 on my overbought indicator, the market doesn’t just ignore it and keep rallying. It pulls back. Yesterday was no different.

But while the broader market is flashing warning signs at resistance, individual setups like AKAM are still delivering exactly what the charts promise.

Why yesterday’s action matters

AKAM tested the $87.50 support level I’ve been marking for weeks — and held it perfectly while SPY was chopping around overhead resistance.

This is what clean technical trading looks like when you focus on individual names instead of getting caught up in index noise.

AKAM’s been building this textbook flag pattern, pulling back on declining volume day after day. That’s not sellers taking control — that’s buyers waiting for their price.

When we tagged $87.50 yesterday and immediately bounced with momentum shifting positive, that was the market showing its hand. Support is real, and the next move is setting up.

The swing trade that’s developing

Here’s what I’m seeing: Clean entry around $88-89, tight stop below yesterday’s proven support at $87.50, and a clear target back toward $95+.

The structure gives us everything we need — a proven floor, controlled pullback, and 2-3 weeks for this to play out.

How I’m actually trading this

I’m using options to maximize the leverage on this setup. With three weeks of time value and AKAM’s manageable volatility, the options structure gives me the exact risk-reward profile I want.

But I’m not sharing those specific strikes, expiration dates, or position sizing here.

That level of detail is what subscribers get in Daily Profits Live — real-time alerts with exact entries, exits, and option strategies as these setups develop.

Why this setup works

Three things aligned yesterday:

• Support held exactly where it should
• Volume patterns confirmed the pullback is over
• Momentum shifted positive on multiple timeframes

When technical analysis works this cleanly, you pay attention.

Your Action Plan

If AKAM pushes through $90 and holds, we’re off to the races. If it breaks below $87.50, the setup’s dead and we move on.

Simple, clean, actionable.

Want the exact options play?

Join Daily Profits Live for real-time alerts with specific strikes, timing, and position management on setups like AKAM.

When the levels work this cleanly, you want the complete trade — not just the idea.

The post The textbook flag pattern everyone ignores appeared first on Trade of the Day.

Today is the day that everyone goes back to work – and starts scouring the internet for deals on holiday shopping.

If that’s the case, we could have a powerful trade setup.

If you read the Black Friday headlines this weekend, you probably saw the same message recycled over and over again:

“Record-Breaking Black Friday!”

“The Consumer Is Back!”

“Spending Surges!”

On the surface, sure – it looks like the American consumer is alive and healthy and ready to keep the spending going.

After all, according to Adobe Analytics, U.S. consumers spent a record $6.4 billion online on Thanksgiving itself, up 5.3% from a year ago.

Mastercard SpendingPulse said U.S. retail sales rose 4.1% compared with Black Friday 2024.

But peel back the veneer… and the story changes from a celebration of consumer strength to a stress signal.

The “Record” That Isn’t a Record

According to Salesforce, despite the strong sales numbers you just read above, shoppers actually bought fewer items per checkout than last year.

In other words…

Retail sales totals went up…

But the actual amount of stuff people bought went down.

This wasn’t a boom in demand – it was a boom in prices.

So, what did this weekend actually prove?

People are paying more to buy the same – or less.

That’s not a strength.

That’s inflation.

The Real Bombshell

Signs of inflation are enough to send shivers up anyone’s spine – especially those on Wall Street.

But the real problem is a new trend that American shoppers love…

Buy now, pay later (BNPL).

This impulsive, unhealthy, instant-gratification-enabling loophole saw spending hit $747.5 million in one day.

That’s 6.3% of all digital sales.

For Black Friday alone, that’s staggering – and it tells me one thing…

Households aren’t spending because they’re flush. Instead, they’re spending because they have access to one more line of credit.

Credit cards… store financing… “zero-interest” promotions…

We’re not watching a healthy consumer.

Instead, we’re watching a consumer stretching tomorrow to survive today – and retailers figuring out slick and creative ways to let it happen.

This is not “demand.” This is desperation disguised as tradition.

And as traders, here’s what we need to understand…

With every situation comes opportunity.

And right now, we have a big one setting up…

Target’s Pain = Amazon’s Gain

As we all know, it’s been rough sledding for Target lately – as bad management/bad messaging decisions have pushed the stock down 45% over the last 5 years.

As the holiday shopping season now gets into high gear, will Target’s ongoing pain mean more opportunity for competitors – namely, Amazon?

That’s a trend that I’d like to zero in on in December.

JPMorgan estimates that e-commerce spending will increase 7% this season. Amazon already controls 46% of the e-commerce market.

If this already substantial lead grows even more, it could be time to get positioned in AMZN for a December run.

YOUR ACTION PLAN

E-commerce plays that don’t rely solely on BNPL models could emerge as the dominant winners here in December, which is something I’m exploring right now on our live trading site, The War Room.

The post Why This Black Friday’s “Record” Is Actually a Warning Signal appeared first on Trade of the Day.

We had several charts on our watchlist, and even with the markets showing volatility at the time, the Cash Code X software is working its magic.

Check out Hershey (HSY), a ticker we were watching during the event.

As you’ll see, HSY flashed a green arrow a few weeks ago, and the stock has been on the rise ever since.

That’s just one example.

Another stock we covered was Alamos Gold (AGI), which had a two stack green arrow grouping.

Again, check out below and you’ll see in the chart how AGI moved up after the indicator.

I know it sounds almost too simple – but that’s how we designed Cash Code X.

All you have to do is follow the green arrow to know when to enter a stock.

The software scans hundreds of tickers, flashes the green arrow, and that’s your cue to enter the trade.

Action Plan: Every trading day, we send you stocks we’re watching in The Wake-Up Watchlist.

Now with Cash Code X, you have the opportunity to use our AI-powered software to create your own customized watchlist in realtime.

And thanks to this simple indicator, you will no longer have to guess when is the best time to buy.

Click here to see how you can target 14x gains in three months… starting today.

The post Why Cash Code X Just Works appeared first on Trade of the Day.